T he NADPH oxidases are superoxide-generating enzymes that release superoxide by electron transfer from NADPH to oxygen. The classical leukocyte NADPH oxidase plays an important role in host defense against bacterial and fungal pathogens. 1, 2 This phagocytic type of NADPH oxidase consists of 2 membrane-bound subunits, gp91 phox and p22 phox which form the flavocytochrome b 558 complex, together with the cyctosolic subunits p40 phox , p47 phox , and p67 phox . Superoxide production by this complex is induced by assembly of the cytosolic and membrane-bound subunits. Such an assembly can be induced by the phosphorylation of p47 phox . 3 Rac GTPases are also involved in this activation process. Recently, several additional isoforms of the membrane-bound subunit gp91
phox have been described. The first described homolog of gp91 phox , called mox1 (later NOX1), is primarily expressed in the colon and is suggested to be involved in mitogenic activity. 4 Additional homologs, including NOX3, NOX4 (Renox), NOX5, Duox1, and Duox2, were subsequently described. [5] [6] [7] [8] According to this new nomenclature, gp91 phox is synonymous with NOX2. It was suggested that each of these homologs can replace gp91 phox in the NADPH oxidase complex, and it has been demonstrated that these nonphagocytic NADPH oxidases release lower amounts of superoxide. 9, 10 However, very recently 2 new isoforms of the cytosolic subunits p47 phox and p67 phox have been identified. These new subunits, NOXO1 and NOXA1, have been demonstrated to interact with NOX1 to generate significant amounts of superoxide without being activated by protein kinase C-dependent phosphorylation. 11, 12 Isoforms of gp91 phox have been identified in different organs and cell types, including the colon, kidney, uterus, testis, liver, vascular smooth muscle cells, fibroblasts, endothelial cells, pancreatic islets, and lymphocytes. 1, 3, 9, [13] [14] [15] The NOX2 homologs have been suggested to be associated with the development of atherosclerosis, systemic hypertension, diabetic vascular disease, and diseases of the brain. 16 The 2 vascular isoforms, NOX1 and NOX4, are thought to play a role in vascular pathology. 17, 18 However, with respect to the lung, relatively few reports of expression and regulation of the recently-identified new vascular NADPH oxidase subunits exist.
Hoidal and coworkers 19 have demonstrated that NOX4 is the predominant homolog in human airway and pulmonary artery smooth muscle cells. 20 In addition Hohler et al identified a low output NADPH oxidase in pulmonary artery endothelial cells. 21 Against this background, we screened the lung for expression of the new NADPH oxidase isoforms. We sought to assess the regulation of the various isoforms, including the classical phagocytic NADPH oxidase subunits by hypoxia because (1) NADPH oxidases recently have been proposed as possible pulmonary oxygen sensors for the acute response to lung alveolar hypoxia (hypoxic pulmonary vasoconstriction), (2) reactive oxygen species are thought to play a role in the vascular remodeling that occurs during chronic alveolar hypoxia, 22, 23 and (3) the phagocytic RT-PCR screening for NADPH oxidase subunits in various mouse organs, and real time PCR quantification of NADPH oxidase subunits in homogenized lungs after 3 days and 3 weeks of hypoxia. a, Analysis by RT-RCR of RNA extracts from homogenized tissue. An ethidium bromidestained gel is illustrated. b and c, Real-time PCR quantification of NADPH oxidase subunits in the lung homogenate after 3 days (duplicate measurements from 3 independent lungs, b) or 3 weeks (duplicate measurements from 5 independent lungs, c) of hypoxia. *Significant difference compared with normoxic controls; boxes, percentiles 25 and 75; black bar, median; whiskers, percentiles 0 and 100; Oϭvalue is more than 1.5 lengths of a box away from the edge of a box.
NADPH oxidase subunit NOX2 has recently been suggested to play an important role in hypoxia-induced pulmonary hypertension. 24 The hypoxia-induced vascular remodeling process is characterized by hypertrophy and de novo muscularization of the vessel media, leading to a decrease in vascular luminal area, increased vascular resistance, and thus development of pulmonary hypertension and right ventricular hypertrophy. 25 In essence, we found that NOX4 is the only subunit prominently upregulated in pulmonary arterial vessels and in smooth muscle cells during chronic hypoxia, both at the transcriptional and protein level. Cell culture experiments demonstrated a proproliferative activity of NOX4 during hypoxia, because targeted knock-down of NOX4 with siRNA suppressed pulmonary arterial smooth muscle cell (PASMC) proliferation. Most interestingly, NOX4 expression was upregulated in the vessel media of lungs from patients with idiopathic pulmonary hypertension (IPAH), in comparison to lungs from healthy donors, suggesting an important role of this NADPH oxidase subunit in human IPAH.
Materials and Methods

Chronic Hypoxia Exposure
All animal experiments were approved by local authorities. Mice (C57BL/6N) of either sex (Charles River Laboratories, Sulzfeld, Germany; 20 to 22 g) were exposed to normobaric hypoxia [inspiratory O 2 fraction (FiO 2 ) 0.10] in a ventilated chamber for up to 3 weeks as described previously. 26 
Mouse Lung Preparation for Laser Assisted Microdissection and Right Heart Hypertrophy Assessment
Mouse lungs were prepared as described previously. 27 For details see the supplemental materials (available online at http://circres. ahajournals.org).
Laser-Assisted Microdissection
Laser-microdissection was performed as described previously. 27
RNA-Extraction and RT-PCR
The RNA was extracted from cells using guanidine thiocyanate-acid phenol (RNAzol B, WAK-Chemie, Germany) or with spin-columns Figure 2 . NOX4 and NOX2 mRNA quantification of microdissected pulmonary arteries by real time PCR during development of hypoxia-induced pulmonary hypertension. a and b, Microdissected small pulmonary arteries (Ϸ100-m diameter) from cryosections of mouse lungs were used for the quantification of NOX4 and NOX2 mRNA. Mice were maintained under normoxic or hypoxic conditions for up to 21 days. The NOX2 and NOX4 mRNA levels were quantified by real-time PCR normalized to ␤ 2 -microglobulin mRNA levels. c, Delta Ct values of NOX4 and NOX2 from microdissected mouse pulmonary arteries of normoxic mice. Values are duplicate measurements of nϭ16 vessels from nϭ3 lungs each. d, Right ventricular hypertrophy after exposure of mice to chronic hypoxia. The right ventricle (RV) to left ventricle (LV) ϩ septum (S) ratio was quantified from mouse hearts after exposure to chronic hypoxia (10% O 2 for 3, 7, and 21 days, respectively, nϭ5). *Significant differences as compared with normoxic controls.
(RNeasy, Qiagen, Germany). For details see the supplemental materials.
Real-Time PCR
Relative quantification of the NADPH oxidase subunits was done using ABI prism 7700 detection system (Applied Biosystem, Weiterstadt, Germany). For details please refer to the supplemental materials.
In Situ Hybridization
For a detailed description of the in situ hybridization protocol please refer to the supplemental materials.
Immunohistochemistry for Mouse Lung Sections
Immunohistochemistry was performed as described previously. 26 For details see the supplemental materials.
Immunohistochemistry for NOX4 and NOX2 in Human Lung Sections
Lung tissue samples from healthy individuals and from patients with IPAH were formalin-fixed, paraffin-embedded, and cut into 3-m sections. The immunostaining of the human lung sections was performed with a custom-made rabbit anti-human NOX4 polyclonal antibody 29 or rabbit anti-human NOX2 polyclonal antibody (Upstate, Germany) as previously described. 26, 28 Western Blot of NOX4 in Frozen Human Lung Tissue
For the detection of NOX4 by Western blot, a custom-made polyclonal anti-NOX4 antibody raised in rabbits was used. 28 For details see the online supplemental materials.
Cell Culture
Smooth muscle cells from human and murine pulmonary arteries were isolated and cultured as described previously. 29, 30 For the investigation of the effect of hypoxia on NOX4 mRNA levels, cells were either exposed to 1% O 2 (hypoxia) or to 21% O 2 (normoxia).
Immunocytochemistry of Murine PASMCs
Isolated PASMCs were cultured on chamber slides, treated as indicated, fixed in ice cold acetone and methanol 
RNA Interference and Proliferation Assay
A detailed description of the siRNA transfection and the proliferation assay is available in the supplemental materials. 
Statistics
Results
To investigate the role of NADPH oxidases in the development of hypoxia-induced pulmonary hypertension, expression of the NADPH-oxidase subunits NOX1, NOX2, NOX4, p22phox, p40phox, p47phox, p67phox, as well as NOXO1 and NOXA1, was assessed by RT-PCR in different mouse tissues. As evident from Figure 1a , all subunits were detected in the colon, heart, lung, and pulmonary arteries. In pulmonary arteries p22 phox , p47 phox , NOX2, and NOX4 appeared to be more prominently expressed, as compared with the other subunits investigated (Figure 1a) . Focusing on the hypoxic regulation of NADPH oxidase subunits in mouse lungs, NOX4 was the only subunit significantly upregulated in homogenized tissue over the timecourse of exposure to chronic hypoxia (Figure 1b and 1c) . In contrast NOX2, NOXA1, and p67phox were not significantly regulated and NOX1 as well as the other cytosolic NADPH oxidases exhibited an overall downregulation after 21 days of chronic hypoxia (Figure 1b and 1c) . Considering that NOX4 was prominently upregulated and NOX2 was previously suggested to play an important role in hypoxia-induced pulmonary hypertension, 24 we next investigated the expression of NOX4 and NOX2 in microdissected small pulmonary arterial vessels (Ϸ100 m diameter), the major site of pulmonary vascular remodeling in chronic hypoxia by real-time PCR (Figure 2a through 2c). Comparing these vessels from animals exposed to normoxic (21% O 2 ) and chronic hypoxic (10% O 2 ) conditions for up to 3, 7, and 21 days, it was observed that NOX4 mRNA conditions. a, In normoxic mice, NOX4 immunoreactivity was not detected in the majority of vessels (arrows). b, Under hypoxia, the majority of vessels were immunoreactive for NOX4 (arrows). Note the slightly autofluorescent bronchial epithelium (arrowhead). c and d, Labeling of NOX4 and ␣-smooth muscle actin (SMA), confocal image. A subgroup of SMA-immunoreactive cells in the vessel wall was also NOX4 immunoreactive (arrows), as evident for the merged images c and d (e). f, Percentage of NOX4 immunoreactive vessels in normoxic mice and mice exposed to chronic hypoxia (10% O 2 ) for up to 21 days. The mean value for every animal is shown in the box plot. g, Mean diameter of NOX4 immunoreactive vessels during development of hypoxia-induced pulmonary hypertension. The mean value for every animal is shown in the box plot; nϭnumber of animals examined per experimental condition, *PϽ0.05; boxes, percentiles 25 and 75, black bar, median; whiskers, percentiles 0 and 100; Oϭvalue is more than 1.5 lengths of a box away from the edge of a box.
expression was upregulated in the pulmonary arteries over the course of exposure to hypoxia, with the highest elevation after 3 weeks (Figure 2a ). In contrast to NOX4, no regulation of NOX2 was observed (Figure 2b ). Under normoxic conditions NOX2 mRNA levels were not different from those of NOX4 ( Figure  2c ). The hypoxic upregulation of NOX4 paralleled the development of pulmonary hypertension in mice induced by chronic hypoxia. The ratio of the right to the left ventricular mass was 0.27Ϯ0.01 in mice maintained under normoxic conditions, and increased to 0.28Ϯ0.03, 0.31Ϯ0.02, and 0.37Ϯ0.01 (nϭ5 each) after 3, 7, and 21 days of hypoxia, respectively (Figure 2d ). In situ hybridization demonstrated NOX4 mRNA expression in different cell types with prominent presence in the vessel media, as confirmed by its colocalization with ␣-smooth muscle actin (Figure 3a through  3f) . Nonvascular area that stained positive for NOX4 mRNA ( Figure 3 ) comprises bronchial smooth muscle cells and may include alveolar type II cells. In this regard we detected NOX4 transcripts in isolated type II cells from the mouse (supplemental Figure I ). Our observations that NOX4 mRNA was the predominant NOX mRNA present in the vessel media was also confirmed on the protein level (Figure 4 ). NOX4 immunoreactivity was observed in a subset of cells of the medial wall of the pulmonary artery, as well as in some smaller pulmonary arteries (Figure 4a through 4e) . After exposure to chronic hypoxia, the number of NOX4-positive vessels was significantly increased after 3 days of exposure to hypoxia (Figure 4f ). The number of small NOX4 immunopositive vessels was also significantly increased after 7 and 21 days of hypoxia (Figure 4g ), indicating that the newly-formed smaller vessels were also NOX4-immunoreactive. At the sub-cellular level, NOX4 protein exhibited a predominantly perinuclear localization in mouse PASMCs with increased intensity after 48 hours of hypoxic incubation ( Figure 5 ).
Histological staining of human lung sections from healthy donors and from patients with idiopathic pulmonary arterial hypertension (IPAH) confirmed NOX4 expression in the vessel media of the pulmonary arteries (Figure 6a through  6d) . In contrast to NOX4 we found that NOX2 was primarily expressed in the endothelial layer of the human pulmonary arteries (Figure 6e and 6f) . Western blot analysis revealed a significant (PϽ0.001) 2.5-fold higher NOX4 protein level in lungs from IPAH patients compared with healthy donor lungs (Figure 7a , full blot and specificity of the NOX4 antibody see supplemental Figure IIa ). In addition, NOX4 transcripts quantified by real-time PCR were increased in human donor PASMCs from passage 3 exposed to hypoxia for 24 hour, compared with normoxic controls (Figure 7b ). To confirm a functional role for NOX4 in cell proliferation, we demonstrated that siRNA directed against human NOX4 significantly reduced the NOX4 mRNA level (Figure 8a and suppressed the proliferation of human passage 3 PASMCs (Figure 8b ) correlating with a decrease of reactive oxygen species (ROS) generation (Figure 8c ). Reduced proliferation of human PASMCs after siNOX4 treatment was additionally confirmed by cell counting (supplemental Figure III) . As previously reported for systemic and PASMCs the NOX4 levels decreased with higher passages (supplemental Figure  IVa) . 20, 31 However, siRNA against NOX4 decreased cell proliferation of both passage 3 and passage 5 cells with higher efficacy in passage 5 cells (see supplemental Figure IVb) .
Discussion
No extensive analysis of the expression of the NADPHoxidase subunits, particularly nonphagocytic NADPH oxidase subunits, in the lung and their regulation in hypoxia has been performed to date. Thus, in screening for the expression of the NADPH oxidase subunits NOX1, NOX2, NOX4, p22 phox , p40phox, p47 phox , p67 phox , NOXA1, and NOXO1 in different mouse organs, it was observed that all of these subunits could be detected by RT-PCR in lung tissue with a similar signal intensity compared with the colon and heart 
( Figure 1a) . In 2 recent investigations, elevated expression of NOX1 and NOX4 was demonstrated for the colon and kidney by Northern blotting. 4, 32 In a previous study, we identified NOX1 in homogenized rabbit lungs and in PASMCs. 33 Recently, NOX4 was suggested to be the predominant NOX2 homolog in human airway PASMCs, 19, 20 and Liu and colleagues provided evidence that the phagocytic NADPH oxidase subunit NOX2 plays an important role in the development of hypoxia-induced pulmonary hypertension. 24 Investigations into the recently identified new isoforms of phagocytic NADPH oxidase subunits in the lung is of interest, because NADPH oxidases have been proposed as possible pulmonary oxygen sensors. 19, 22 Suliman and coworkers supported a possible role for NOX4 in the context of oxygen sensing in the mouse kidney, demonstrating induced expression of the renal-specific NADPH oxidase (NOX4) under hypoxic conditions. 34 With respect to the lung vasculature, oxygen sensing is important under circumstances of acute hypoxia (lasting seconds to minutes) as well as of chronic hypoxia (lasting days to months and years). Acute alveolar hypoxia induces constriction of pulmonary arterial vessels, which is an essential mechanism to adapt perfusion to ventilation, and thus to optimize pulmonary gas exchange. 22, 35 Recently we have demonstrated that a nonphagocytic NADPH oxidase may play an important role in the acute hypoxic response of the pulmonary arteries in the lung. 23 In contrast, chronic alveolar hypoxia induces remodeling of the pulmonary vasculature, characterized by hypertrophy of the vessel media, and thus a narrowing of the vascular lumen. This leads to an increased pulmonary vascular resistance, pulmonary hypertension, and ultimately resulting in right heart failure. For both acute and chronic alveolar hypoxia, a possible role for reactive oxygen species has been widely discussed 19, 22, 35, 36 and the phagocytic NADPH oxidase NOX2 has been demonstrated in a knockout mouse model to be of major importance for the development of hypoxia-induced pulmonary hypertension. With respect to an additional role for nonphagocytic NADPH oxidase subunits in the pathophysiology of hypoxia-induced pulmonary hypertension, the present study focused on NOX4, because: (1) NOX4 is the only nonphagocytic NADPH oxidase subunit prominently expressed in pulmonary arteries, (2) NOX 4 was the only NADPH oxidase subunit upregulated in chronic hypoxia in homogenized mouse lung tissue (Figure 1b and  1c) , (3) NOX4 acts as an oxygen sensor to regulate TASK-1 activity in HEK 293 cells, and (4) it was recently suggested that this subunit may contribute to pathophysiological changes in the systemic vasculature and in the pulmonary arteries. 1, 10, 20, 37 Moreover, we compared the regulation of NOX4 to that of NOX2 considering the recent findings by Liu et al. 24 As remodeling of small pulmonary arteries is thought to be the major cause of the increase in vascular resistance occurring during chronic hypoxia, we focused on the hypoxia-dependent regulation of NOX4 and NOX2 mRNA in these vessels of the murine pulmonary vasculature. Our analysis revealed that NOX4, in contrast to NOX2, is elevated in the pulmonary vasculature by chronic hypoxia: upregulation of NOX4 but not of NOX2 occurred in the pulmonary arteries within 21 days of exposure to hypoxia, as demonstrated by quantitative PCR of microdissected vessels. Moreover, in situ hybridization revealed that NOX4 transcripts were localized to the pulmonary artery smooth muscle layer. The hypoxia-dependent increase in NOX4 expression levels in the pulmonary vasculature correlated well with the development of pulmonary hypertension, 38 and was corroborated further at the protein level: (1) NOX4-immunoreactivity was detected in the pulmonary vasculature β Figure 7 . Detection of NOX4 by Western blot in human donor and IPAH lungs and hypoxiainduced upregulation of NOX4 in isolated PASMCs. a, Western blots of human IPAH lungs (nϭ4) compared with healthy donor lungs (nϭ6) revealed a 2.5-fold upregulation of NOX4 expression in human IPAH lungs (specific band at 64 kDa). The NOX4 was normalized to ␤-actin. The full blot as well as the specificity of the antibody is shown in supplemental Figure IIa. *Significant difference as compared with donor lungs. b, Isolated human PASMCs were maintained under hypoxic (1% O 2 ) or normoxic (21% O 2 ) conditions for 24 hours. The NOX4 mRNA levels were quantified by real-time PCR and standardized to ␤ 2 -microglobulin mRNA levels. A significant increase in NOX4 mRNA was observed after 24 hours of hypoxic vs normoxic treatment (*). Data are derived from duplicate measurement of nϭ3 independent cell preparations. by immunostaining, and (2) the percentage of NOX4 immunoreactive vessels was strongly increased by chronic alveolar hypoxia with an increase in the number of NOX4-positive small vessels. The upregulation at the protein level ( Figure  4f ) preceded the regulation on the mRNA level (Figure 2a ). This suggests that NOX4 can be regulated on both the mRNA and the protein level. It was also evident from immunohistochemical data that the upregulation of NOX4 occurs in the vessel media, further supporting the idea that NOX4 contributes to the pathophysiological process of hypoxia-induced vascular remodeling in the lung, which is triggered by ROS-dependent smooth muscle cell proliferation. In line with this observation and the recent finding of Sturrock et al, the silencing of NOX4 by siRNA reduced human PASMC proliferation as well as ROS generation. 20 A possible role for NOX4 in the pathogenesis of pulmonary hypertension in general was supported by the fact that NOX4 is upregulated in the vessel media of lung sections from patients with IPAH, compared with healthy donor lungs. The perinuclear localization of NOX4 in the PASMCs supports the notion of the presence of the protein in the endoplasmic reticulum (ER), as recently demonstrated in microvascular endothelial cells by Petry and coworkers. 39 The presence of NOX4 in the ER further suggests an important role of NOX4 in maintaining the redox potential and Ca 2ϩ -homeostasis in PASMCs. 40 The findings of Liu et al that NOX2 is essential for development of hypoxia-induced pulmonary hypertension, together with the fact that we as well as Liu et al were unable to detect regulation of NOX2 in pulmonary arteries by hypoxia, are suggestive that NOX2 and NOX4 play a differential role in the development of hypoxia-induced pulmonary hypertension. Hypothetically, endothelial ROS generation by NOX2 may stimulate NOX4 upregulation in the vessel media, which would be important for hypoxia-dependent PASMC proliferation. In line with this argumentation is the detection primarily of NOX2 in pulmonary vascular endothelial cells in our study, as well as 2 recent reports demonstrating a ROS-dependent upregulation of NOX4 in cardiac cells. 41, 42 The fact that NOX4 is upregulated in the vessel media in both hypoxia-induced pulmonary hypertension and in human IPAH may be explained by distinct or common regulators of NOX4. With regard to the latter it has been shown that TGF-␤ can upregulate NOX4 in human PASMCs, 20 that hypoxia can increase TGF-␤ in PASMCs, 43 and that interference with TGF-␤ blocks hypoxia-induced vascular remodeling. 44 Interestingly, it has been shown that TGF-␤ can vice versa be regulated by ROS. 45 Thus, hypoxia-induced and human IPAH may share some common pathophysiological mechanisms with regard to NOX4.
In conclusion, we demonstrate in the present study that all major subunits of the phagocytic as well as nonphagocytic NADPH-oxidase subunits are expressed in the lung. Furthermore, NOX4 was found to be upregulated in the pulmonary vasculature, both in chronic hypoxic pulmonary hypertension as well as in human IPAH. The correlation of NOX4 expression with the development of pulmonary hypertension suggests a contribution of NOX4 to the development of this disease. With respect to the upregulation of NOX4 in IPAH patients, a functional interference with NOX4 may offer a new therapeutic approach for the treatment of this disease.
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EXPANDED MATERIALS AND METHODS
Mouse lung preparation for laser assisted microdissection and right heart hypertrophy assessment.
After 3, 7 and 21 days of hypoxia, the animals were euthanized by intraperitoneal injection of a lethal ketamine and xylazine dose, and the lungs were flushed with Krebs Henseleit buffer (125.0 mM NaCl, 4.3 mM KCl, 1.1 mM KH 2 PO 4 , 2.4 mM CaCl 2 , 1.3 mM MgCl 2 and 13.32 mM glucose) through a catheter in the pulmonary artery at a pressure of 20 cm H 2 O at room temperature. The buffer was preequilibrated with a gas mixture of 3%O 2 , 5.3%CO 2 , balanced N 2 . NaHCO 3 was adjusted to result in a pH of 7.4. During perfusion of the lungs, the buffer was allowed to drain freely from a catheter in the left ventricle. Once the effluent was clear of blood, lungs were dissected from the thoracic cavity and immediatley frozen in liquid nitrogen for mRNA analysis.
For immunohistochemistry, in situ hybridization and laser assisted microdissection, 800 µl prewarmed TissueTek ® (Sakura Finetek, Zoeterwoude, The Netherlands) was instilled into the airways via a tracheal cannula. After ligation of the trachea, the lungs were excised and immediately snap frozen in melting isopentane. Preparation of the hypoxic animals was performed continuously in a hypoxic environment (10% O 2 ). Lungs from normoxic animals (control) were prepared accordingly under normoxic conditions. The right ventricular wall (RV) was separated from the left ventricle plus septum (LV+S) to calculate the ratio of RV/(LV+S) of the dehydrated heart tissue. For analysis of colon, heart, and pulmonary arteries, these tissues and organs were removed immediately after the lung had been flushed.
RT-PCR
For reverse transcription (RT) of extracted RNA, 1 µg of total RNA was denatured at 65 °C for 5 min.
After cooling on ice, the following components were added to the samples: 5 µl of 5× RT buffer, 2 µl Table I .
Real-time PCR
All primers used in the real time PCR experiments were intron-spanning. The Ct values of NOX4
were normalized to the endogenous control B2M (β 2 -microglobulin) in both mouse and human samples ( 1 ). For cDNA synthesis reagents and incubation time were applied as described before ( 2 ).
The fold change 2 ∆∆Ct was calculated as described previously ( 3 ).For the sequences primers used in real time PCR please see Online Table II .
Riboprobes for in situ hybridization
Single-stranded digoxigenin (DIG)-labeled riboprobes for non-isotopic in situ hybridization were generated by the in vitro transcription method. The template for the generation of single-stranded 
Type II cell isolation
Mouse alveolar type II cells were isolated as described previously ( 4 ).
Immunohistochemistry for mouse lung sections
Cryosections ( emission: 560 nm). A total of eight images was captured from each group in a blinded fashion and were quantified using Image J software (U.S. National Institutes of Health, Bethesda, MD).
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